$Rebecca Marsh and Grant Schulert on allogeneic HSCT for children with refractory sJIA and associated lung disease$

Rebecca Marsh and Grant Schulert on allogeneic HSCT for children with refractory sJIA and associated lung disease

Update: 2025-03-24

Description

The first episode of a mini series on cell-based therapies in rheumatology, with Prof Rebecca Marsh and Grant Schulert discussing the use of allogeneic haematopoietic stem-cell transplantation for children with refractory systemic juvenile idiopathic arthritis and associated lung disease.

Read the full article:

https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(24)00275-3/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanrhe

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Comments

In Channel

Scott Uhlrich on personalised gait retraining for knee osteoarthritis

2025-09-2216:26

Mark Hancock on low back pain

2025-08-1810:20

Vibeke Strand on polymyalgia rheumatica

2025-07-2111:32

Xue Li on access to biologics in the Asia-Pacific region

2025-06-2019:31

Sinisa Savic on treatment outcomes in VEXAS syndrome

2025-06-1612:07

Fabian Müller and Melanie Hagen on a newly discovered toxicity of CD-19 targeting CAR T-cell therapy

2025-06-0320:50

Dominique Farge on allogeneic umbilical cord-derived mesenchymal stromal cells for systemic lupus erythematosus

2025-04-2526:05

$Rebecca Marsh and Grant Schulert on allogeneic HSCT for children with refractory sJIA and associated lung disease$

Rebecca Marsh and Grant Schulert on allogeneic HSCT for children with refractory sJIA and associated lung disease

2025-03-2418:30

Bryant England on advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung disease

2025-02-2408:30

Brooke Conley and Ivan Lin on the development of arthritis educational resources for Aboriginal and Torres Strait Islander peoples in Australia

2025-01-2718:30

Mark Russell and Sherry Yang on the inequities in rheumatological care in the UK and USA

2024-12-2325:28

Quirine Dumoulin on the 4-year data from the TREAT-EARLIER trial

2024-11-2515:38

Sebastian Sattui on older adults with ANCA-associated vasculitis

2024-10-2125:54

Celebrating 5 years of The Lancet Rheumatology with Oliver Distler, Laura Coates, and David Liew

2024-09-2358:02

Karen Schreiber, Ian Giles, and Angela Tincani on the Pregnancy and Rheumatic Diseases Series

2024-07-2234:33

Dr Maria Tektonidou on cardiovascular risk factors in systemic lupus erythematosus

2024-06-1711:20

Rosemary Hollick on improving services for adults with rare autoimmune rheumatic diseases

2024-05-2116:17

Clinical Realities: Heather Van Epps, Anna Clark, Lola Falasinnu, David Liew, and Puja Mehta

2023-01-1825:35

Clinical Realities: Sex and Gender in Research Design and Reporting from The Lancet Summit

2022-10-1238:53

Clinical Realities: Randy Cron, Chandrika Bhat, and Puja Mehta

2022-08-2533:07

00:00

$Rebecca Marsh and Grant Schulert on allogeneic HSCT for children with refractory sJIA and associated lung disease$

Rebecca Marsh and Grant Schulert on allogeneic HSCT for children with refractory sJIA and associated lung disease

#box-pro-ellipsis-175999316219071{-webkit-line-clamp:2;}Rebecca Marsh and Grant Schulert on allogeneic HSCT for children with refractory sJIA and associated lung disease

Rebecca Marsh and Grant Schulert on allogeneic HSCT for children with refractory sJIA and associated lung disease

The Lancet Group

Rebecca Marsh and Grant Schulert on allogeneic HSCT for children with refractory sJIA and associated lung disease